Key Drivers
- Margin Expansion
- Strong Liquidity
- Elevated Leverage
AIAI Summary
SHC is best viewed as a cash-flow conversion and deleveraging thesis: its durable, high-margin regulated-services franchise supports growth, but a rerating depends on delivering $500–$600M of 2025–27 free cash flow and lower 2027 capex to reduce leverage and improve thin interest coverage.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Expansion
- •Strong Liquidity
- •Elevated Leverage
SHC's profitability, cash flow, and liquidity improved, but high leverage, negative retained earnings, intangible-heavy assets, and demanding valuation warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Failed rally
- •Support defended
- •Below average
SHC remains neutral-to-cautiously negative over the last month, with support at $18.25–$18.35 and a bullish improvement only if it sustains above $19.05.
Rebounded sharply from $18.26 to $19.33 before reversing
Sentiment & News
Key News Insights:
- •Raised guidance
- •Durable revenue
- •Institutional buying
Sotera Health's strong Q2 beat, raised guidance, durable revenue model, and supportive institutional buying signal a constructive outlook despite mixed ownership activity.
The news is likely positive for SHC valuation and investor sentiment
Similar Companies in Healthcare
Other companies in the same sector with AI ratings